Herbalife Rg
HLF
USD
STOCK MARKET:
NYX
Closed
 
...
Large gap with delayed quotes
Last quote
08/29/2025 - 22:15:00
Bid
08/29/2025 - 21:59:59
Bid
Volume
Ask
08/29/2025 - 21:59:59
Ask
Volume
9.78
+0.61 ( +6.65% )
9.78
28,300
9.79
39,500
More information
Analysis by TheScreener
29.08.2025
Evaluation Neutral  
Interest Strong  
Sensibility High  
Analysis date: 29.08.2025
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 29.08.2025.
Interest
  Strong
Three stars since 29.08.2025.
Earnings Rev Trend
  -0.10
 
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 10.06.2025 at a price of 8.27.
Evaluation
  Undervalued
 
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
  Positive
 
The dividend-adjusted forty day technical trend is positive since 27.05.2025.
4wk Rel Perf
  2.20%
 
The four-week dividend-adjusted overperformance versus SP500 is 2.20%.
Sensibility
  High
High, no change over 1 year.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.37%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 4.53%.
Mkt Cap in $bn
  1.01
With a market capitalization <$2bn, HERBALIFE is considered a small-cap stock.
G/PE Ratio
  2.55
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
  3.91
The estimated PE is for the year 2026.
LT Growth
  9.97%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
  3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  37
For 1% of index variation, the stock varies on average by 0.37%.
Correlation
  0.11
Stock movements are totally independent of index variations.
Value at Risk
  3.37
The value at risk is estimated at USD 3.37. The risk is therefore 34.44%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  17.08.2005